Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,152 | 665 | 99.4% |
| Education | $63.00 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,986 | 127 | $0 (2024) |
| Novo Nordisk Inc | $1,167 | 73 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $753.86 | 66 | $0 (2022) |
| PFIZER INC. | $656.51 | 47 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $566.83 | 34 | $0 (2024) |
| Lilly USA, LLC | $555.11 | 48 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $514.05 | 40 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $448.66 | 23 | $0 (2024) |
| GlaxoSmithKline, LLC. | $409.73 | 30 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $365.47 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,481 | 90 | ABBVIE INC. ($261.23) |
| 2023 | $2,857 | 190 | ABBVIE INC. ($603.22) |
| 2022 | $3,821 | 273 | Biohaven Pharmaceutical Holding Company Ltd. ($753.86) |
| 2021 | $1,892 | 111 | AbbVie Inc. ($452.25) |
| 2020 | $19.58 | 1 | Merck Sharp & Dohme Corporation ($19.58) |
| 2018 | $144.09 | 3 | EKOS Corporation ($117.72) |
All Payment Transactions
668 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.09 | General |
| 12/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Diabetes Care | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: DIABETES | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: VACCINES | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: VACCINE | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.22 | General |
| Category: Cardiovascular | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $10.20 | General |
| 10/27/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: VACCINES | ||||||
| 10/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Biological | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,275 | 1,844 | $277,874 | $122,387 |
| 2022 | 24 | 976 | 1,404 | $197,629 | $77,471 |
| 2021 | 10 | 329 | 465 | $55,350 | $27,594 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 142 | 454 | $52,210 | $27,499 | 52.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 143 | 175 | $39,025 | $16,683 | 42.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 174 | 174 | $35,322 | $15,912 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 234 | 340 | $42,556 | $14,093 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 177 | $31,070 | $12,129 | 39.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 139 | 168 | $21,000 | $10,109 | 48.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 56 | 60 | $19,380 | $7,745 | 40.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 12 | $7,980 | $3,380 | 42.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 42 | 42 | $2,814 | $2,758 | 98.0% |
| 99235 | Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day, if using time, at least 70 minutes | Facility | 2023 | 24 | 25 | $7,125 | $2,578 | 36.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $3,526 | $2,402 | 68.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 22 | $3,520 | $2,049 | 58.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $3,185 | $1,401 | 44.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 44 | 44 | $1,936 | $1,292 | 66.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 19 | 19 | $3,021 | $1,239 | 41.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 58 | $2,320 | $552.16 | 23.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $484.00 | $322.96 | 66.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 23 | $1,196 | $215.80 | 18.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 12 | $204.00 | $26.40 | 12.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 97 | 107 | $23,861 | $10,467 | 43.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 143 | 224 | $28,369 | $8,592 | 30.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 129 | 151 | $18,875 | $8,204 | 43.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 53 | 149 | $17,135 | $8,169 | 47.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 100 | 100 | $20,300 | $7,828 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 116 | $19,386 | $6,669 | 34.4% |
About Dr. Jason Ice, DO
Dr. Jason Ice, DO is a Internal Medicine healthcare provider based in Parma, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2018. The National Provider Identifier (NPI) number assigned to this provider is 1467951863.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Ice, DO has received a total of $10,215 in payments from pharmaceutical and medical device companies, with $1,481 received in 2024. These payments were reported across 668 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($10,152).
As a Medicare-enrolled provider, Ice has provided services to 2,580 Medicare beneficiaries, totaling 3,713 services with total Medicare billing of $227,451. Data is available for 3 years (2021–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Parma, OH
- Active Since 02/12/2018
- Last Updated 11/24/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1467951863
Products in Payments
- NURTEC ODT (Drug) $1,077
- UBRELVY (Drug) $708.42
- XIFAXAN (Drug) $514.05
- Ozempic (Drug) $427.87
- XARELTO (Drug) $414.22
- Rybelsus (Drug) $368.85
- TRELEGY ELLIPTA (Drug) $362.99
- JARDIANCE (Drug) $343.90
- VRAYLAR (Drug) $332.22
- QULIPTA (Drug) $324.68
- AirDuo Digihaler (Drug) $256.78
- LINZESS (Drug) $251.44
- Kerendia (Drug) $239.05
- RYBELSUS (Drug) $238.76
- ELIQUIS (Drug) $211.22
- FARXIGA (Drug) $200.36
- MOUNJARO (Drug) $197.92
- FREESTYLE LIBRE 3 (Device) $192.70
- CREON (Drug) $170.96
- Auvelity (Drug) $156.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Parma
Dr. Charles Koepke, Md, MD
Internal Medicine — Payments: $10,439
Florin Penciu, Md, MD
Internal Medicine — Payments: $9,339
Dr. Boris Gliner, M.d, M.D
Internal Medicine — Payments: $7,878
Dr. Morgan Koepke, Md, MD
Internal Medicine — Payments: $7,488
Amir Naraghi, Md, MD
Internal Medicine — Payments: $4,620
Samson Ballesteros, M.d, M.D
Internal Medicine — Payments: $2,354